Clinical Trials Browser

Withdrawn × Multiple Myeloma × Everolimus × Clear all

NCT01234974 2013-01-10

IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus

Phase 2 Withdrawn

Multiple Myeloma